Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves
Open Access
- 19 March 2021
- journal article
- research article
- Published by Ubiquity Press, Ltd. in CVD Prevention and Control
- Vol. 16 (1)
- https://doi.org/10.5334/gh.959
Abstract
Objectives: The aim of the present analysis is to compare the quantitative angiographic aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) among three balloon-expandable valves. Background: Quantitative videodensitometric aortography is an objective, accurate, and reproducible tool for adjudication of AR following TAVI. Methods: This is a retrospective corelab analysis, independent from industry, of aortograms from patients treated with TAVI using the balloon-expandable Myval transcatheter heart valve (THV) (Merit Life Sciences Pvt. Ltd., India), Sapien 3, and XT THVs (Edwards Lifesciences, Irvine, CA, USA). The study comprised of 108 analyzable aortograms from consecutive patients in a multicenter European registry who underwent Myval THV implantation. The results of quantitative assessment of AR in the Sapien 3 THV (n = 397) and Sapien XT THV (n = 239) were retrieved from a published pooled database. Results: The Myval THV had the lowest proportion of patients with moderate or severe angiographic quantitative AR (2.8%) compared to the Sapien 3 THV (8.3%; p = 0.049) and Sapien XT THV (10.9%; p = 0.012). Furthermore, the Myval THV had the lowest mean angiographic quantitative AR (6.3 +/- 6.3%), followed by Sapien 3 THV (7.6 +/- 7.1%) and Sapien XT THV (8.8 +/- 7.5%), and it was significantly lower than that of the Sapien XT THV (p = 0.006), but not significantly different from Sapien 3 THV (p = 0.246). Conclusion: The Myval THV, in comparison with other BEV's analyzed in our database, showed a lower occurrence of moderate or severe AR after TAVI. These results should be confirmed in prospective cohorts of randomized patients with head-to-head THV comparisons.Keywords
This publication has 10 references indexed in Scilit:
- Online Quantitative Aortographic Assessment of Aortic Regurgitation After TAVRJACC: Cardiovascular Interventions, 2021
- Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic StenosisJournal of the American College of Cardiology, 2020
- Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trialAmerican Heart Journal, 2020
- First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 studyEuroIntervention, 2020
- Quantitative Assessment of Acute Regurgitation Following TAVRJACC: Cardiovascular Interventions, 2020
- Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE RegistryEuroIntervention, 2019
- Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk PatientsThe New England Journal of Medicine, 2019
- A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance ImagingJACC: Cardiovascular Interventions, 2018
- Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registryEuroIntervention, 2016
- Transcatheter Aortic-Valve Replacement with a Self-Expanding ProsthesisThe New England Journal of Medicine, 2014